These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1559303)

  • 1. Long-acting gonadotrophin releasing hormone agonist implant causes variable duration of suppression of ovarian steroid and inhibin secretion.
    Fraser HM; Haining R; Cowen GM; Sandow J; Smith KB; Smith SK
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):97-104. PubMed ID: 1559303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months.
    Fraser HM; Sandow J; Seidel H; von Rechenberg W
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):521-7. PubMed ID: 3115020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonist administration in polycystic ovary syndrome.
    Buckler HM; Phillips SE; Kovacs GT; Burger HG; Healy DL
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):151-65. PubMed ID: 2514053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin secretion after treatment with an LHRH agonist and subsequent ovarian hyperstimulation induced by FSH in the macaque (Macaca arctoides).
    Fraser HM; Smith KB; Reddi K; Lunn SF
    J Reprod Fertil; 1990 Jul; 89(2):441-6. PubMed ID: 2119427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H; Jung C; Taubert HD
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of inhibin and gonadotrophin-releasing hormone in the control of gonadotrophin secretion in the ewe.
    Martin GB; Wallace JM; Taylor PL; Fraser HM; Tsonis CG; McNeilly AS
    J Endocrinol; 1986 Nov; 111(2):287-96. PubMed ID: 3098888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis.
    Fraser HM; Sandow J; Cowen GM; Lumsden MA; Haining R; Smith SK
    Fertil Steril; 1990 Jan; 53(1):61-8. PubMed ID: 2104808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer.
    Lockwood GM; Muttukrishna S; Groome NP; Knight PG; Ledger WL
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):741-8. PubMed ID: 9039341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment of endometriosis in women with continuous subcutaneous infusion of gonadotropin-releasing hormone agonist (GnRH-A)].
    Masaoka K; Kitazawa M; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):405-11. PubMed ID: 2501437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gonadotrophin-releasing hormone agonist-induced suppression of LH and FSH on follicle growth and corpus luteum function in the ewe.
    McNeilly AS; Fraser HM
    J Endocrinol; 1987 Nov; 115(2):273-82. PubMed ID: 3125300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids.
    Burger HG; Hee JP; Mamers P; Bangah M; Zissimos M; McCloud PI
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):771-7. PubMed ID: 7889613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between pharmacokinetics and endocrine effects of buserelin implants in patients with mastalgia.
    Klijn JG; van Geel B; de Jong FH; Sandow J; Krauss B
    Clin Endocrinol (Oxf); 1991 Apr; 34(4):253-8. PubMed ID: 1908753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist.
    Gong JG; Campbell BK; Bramley TA; Gutierrez CG; Peters AR; Webb R
    Biol Reprod; 1996 Jul; 55(1):68-74. PubMed ID: 8793060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pituitary-gonadal suppression with a gonadotrophin-releasing hormone agonist on fetal gonadotrophin secretion, fetal gonadal development and maternal steroid secretion in the sheep.
    Thomas GB; McNeilly AS; Gibson F; Brooks AN
    J Endocrinol; 1994 May; 141(2):317-24. PubMed ID: 8046302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic treatment with a gonadotrophin-releasing hormone agonist on peripheral concentrations of FSH and LH, and ovarian function in heifers.
    Gong JG; Bramley TA; Gutierrez CG; Peters AR; Webb R
    J Reprod Fertil; 1995 Nov; 105(2):263-70. PubMed ID: 8568770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
    Daniels M; Newland P; Dunn J; Kendall-Taylor P; White MC
    J Endocrinol; 1988 Sep; 118(3):491-6. PubMed ID: 2460576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.